Comparative effectiveness results for pain outcome analyses, for each of (A) short-term outcomes, (B) medium-term outcomes and (C) long-term outcomes
| A | |||||||
| Placebo | 0.53 (−0.77 to 1.83) | 0.51 (−0.83 to 1.86) | 0.39 (−1.36 to 2.13) | 0.59 (−0.18 to 1.35) | |||
| −0.92(-0.78 to 2.62) |
Steroid Inj +Exe | −1.20 (−2.26 to −0.14) | |||||
| 0.91 (0.14 to 1.68) | −0.01 (−1.73 to 1.70) | Steroid Inj | −0.67(−2.56 to 1.22) | −2.60 (−4.39 to −0.81) | −1.94 (−3.80 to −0.08) | −0.29 (−1.23 to 0.65) | |
| 0.56 (−0.40 to 1.52) | −0.36 (−2.26 to 1.55) | −0.35 (−1.40 to 0.70) | Orthoses | −0.01 (−1.83 to 1.80) | −0.4 (−2.21 to 1.42) | ||
| −1.69 (−3.64 to 0.26) | −2.61 (−5.09 to -0.13) | −2.6 (−4.39 to −0.81) | −2.25 (−4.33 to −0.18) | Oral NSAID | |||
| −0.28 (−1.62 to 1.06) | −1.2 (−2.26 to −0.14) | −1.19 (−2.54 to 0.16) | −0.84 (−2.43 to 0.74) | 1.41 (−0.83 to 3.65) | Exe | ||
| 0.74 (−0.91 to 2.40) | −0.18 (−2.51 to 2.16) | −0.16 (−1.87 to 1.54) | 0.18 (−1.42 to 1.79) | 2.43 (−0.04 to 4.90) | 1.03 (−1.06 to 3.11) |
ESWT +Orthoses | −0.39 (−2.20 to 1.43) |
| 0.55 (−0.08 to 1.19) | −0.37 (−2.12 to 1.39) | −0.35 (−1.08 to 0.37) | −0.01 (−1.00 to 0.99) | 2.24 (0.31 to 4.17) | 0.84 (−0.57 to 2.24) | −0.19 (−1.80 to 1.42) | ESWT |